APA (7th ed.) Citation

B, B., HY, E., Q, W., S, K., C, H., D, K. M., . . . CIE, S. (2025). Cell-penetrating peptide-conjugated, splice-switching oligonucleotides mitigate the phenotype in BTK/Tec double deficient X-linked agammaglobulinemia model. RSC chemical biology, 6(5), 761. https://doi.org/10.1039/d4cb00312h

Chicago Style (17th ed.) Citation

B, Bestas, et al. "Cell-penetrating Peptide-conjugated, Splice-switching Oligonucleotides Mitigate the Phenotype in BTK/Tec Double Deficient X-linked Agammaglobulinemia Model." RSC Chemical Biology 6, no. 5 (2025): 761. https://doi.org/10.1039/d4cb00312h.

MLA (9th ed.) Citation

B, Bestas, et al. "Cell-penetrating Peptide-conjugated, Splice-switching Oligonucleotides Mitigate the Phenotype in BTK/Tec Double Deficient X-linked Agammaglobulinemia Model." RSC Chemical Biology, vol. 6, no. 5, 2025, p. 761, https://doi.org/10.1039/d4cb00312h.